oncology

Echo Immune is developing personalised mRNA cancer vaccines designed from a patient's own tumour to stop cancer coming back after treatment.

Invocata is building personalised T-cell receptor therapies, choosing the right TCR for the individual patient at the right time; its site says only that it is coming soon.

Kernis Health helps cancer patients keep their own living tumour tissue after surgery, instead of letting it be discarded, so it can be used later for functional drug testing, diagnostics and trial access.

Minuteman Therapeutics develops oncolytic viruses engineered against an individual patient's tumour, matching the virus to the biology of that person's cancer.

Palitra Bio tests candidate treatments directly against a patient's own tumour cells, with a PhD data team and an MD tumour board turning the results into a personalised treatment plan.

Ranata Therapeutics builds antibodies and bispecific antibodies against the unique features of an individual patient's cancer cells.

Relit Biosciences gives patients access to biomarker-based imaging and radioligand therapy, the pairing of a diagnostic scan with a matched radioactive drug.

Valius is a patient-centred multi-omic profiling service that runs whole genome, bulk and single-cell RNA, spatial transcriptomics, high-plex protein, and ctDNA on one tumour.

Yuga Bio is an AI workspace for personalised cancer care: a patient's case wiki, agentic research on their tumour and their care team in one place, from diagnosis to treatment options.